These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 12497008
21. Resource utilization for ovarian cancer patients at the end of life: how much is too much? Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ. Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364 [Abstract] [Full Text] [Related]
22. Economical data and advanced prostate carcinoma: do we need new guidelines for decision making? Rohde V, Wellmann A, Fogt F, Weidner W, Katalinic A. Oncol Rep; 2002 Nov; 9(6):1185-8. PubMed ID: 12375016 [Abstract] [Full Text] [Related]
23. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [Abstract] [Full Text] [Related]
24. Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma. Konski A, Watkins-Bruner D, Brereton H, Feigenberg S, Hanks G. Cancer; 2006 Jan 01; 106(1):51-7. PubMed ID: 16323171 [Abstract] [Full Text] [Related]
25. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. McNaughton-Collins M, Walker-Corkery E, Barry MJ. J Natl Cancer Inst Monogr; 2004 Jan 01; (33):78-101. PubMed ID: 15504921 [Abstract] [Full Text] [Related]
26. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. J Urol; 2007 Jun 01; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [Abstract] [Full Text] [Related]
27. Prostate cancer. Penson DF, Chan JM, Urologic Diseases in America Project. J Urol; 2007 Jun 01; 177(6):2020-9. PubMed ID: 17509282 [Abstract] [Full Text] [Related]
28. Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer. Homma Y, Akaza H, Okada K, Yokoyama M, Usami M, Hirao Y, Tsushima T, Sakamoto A, Ohashi Y, Aso Y, Prostate Cancer Study Group. Int J Urol; 2004 Apr 01; 11(4):218-24. PubMed ID: 15028100 [Abstract] [Full Text] [Related]
29. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR. J Natl Cancer Inst; 2007 Oct 17; 99(20):1516-24. PubMed ID: 17925537 [Abstract] [Full Text] [Related]
30. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results. Homma Y, Akaza H, Okada K, Yokoyama M, Moriyama N, Usami M, Hirao Y, Tsushima T, Sakamoto A, Ohashi Y, Aso Y, Prostate Cancer Study Group. Int J Urol; 2004 May 17; 11(5):295-303. PubMed ID: 15147545 [Abstract] [Full Text] [Related]
31. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer. D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ. J Urol; 2006 Dec 17; 176(6 Pt 2):S11-5. PubMed ID: 17084157 [Abstract] [Full Text] [Related]
32. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project). Hallert E, Husberg M, Skogh T. Rheumatology (Oxford); 2006 Mar 17; 45(3):325-31. PubMed ID: 16287927 [Abstract] [Full Text] [Related]
33. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy. Kroepfl D, Loewen H, Roggenbuck U, Musch M, Klevecka V. BJU Int; 2006 May 17; 97(5):985-91. PubMed ID: 16643480 [Abstract] [Full Text] [Related]
34. Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. Akaza H, Homma Y, Usami M, Hirao Y, Tsushima T, Okada K, Yokoyama M, Ohashi Y, Aso Y, Prostate Cancer Study Group. BJU Int; 2006 Sep 17; 98(3):573-9. PubMed ID: 16925756 [Abstract] [Full Text] [Related]
35. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F, Epstein JI. Am J Surg Pathol; 2008 Jul 17; 32(7):1060-7. PubMed ID: 18496142 [Abstract] [Full Text] [Related]
36. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Michaud K, Messer J, Choi HK, Wolfe F. Arthritis Rheum; 2003 Oct 17; 48(10):2750-62. PubMed ID: 14558079 [Abstract] [Full Text] [Related]
37. Radical prostatectomy for clinical T4 prostate cancer. Johnstone PA, Ward KC, Goodman M, Assikis V, Petros JA. Cancer; 2006 Jun 15; 106(12):2603-9. PubMed ID: 16700037 [Abstract] [Full Text] [Related]
38. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. J Urol; 2009 Aug 15; 182(2):517-25; discussion 525-7. PubMed ID: 19524984 [Abstract] [Full Text] [Related]
39. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol; 2008 May 15; 179(5):1830-7; discussion 1837. PubMed ID: 18353378 [Abstract] [Full Text] [Related]
40. Cost of care for elderly cancer patients in the United States. Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML. J Natl Cancer Inst; 2008 May 07; 100(9):630-41. PubMed ID: 18445825 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]